222 related articles for article (PubMed ID: 35078507)
1. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.
Yin L; Li Q; Mrdenovic S; Chu GC; Wu BJ; Bu H; Duan P; Kim J; You S; Lewis MS; Liang G; Wang R; Zhau HE; Chung LWK
Breast Cancer Res; 2022 Jan; 24(1):7. PubMed ID: 35078507
[TBL] [Abstract][Full Text] [Related]
2. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.
Li Q; Yin L; Jones LW; Chu GC; Wu JB; Huang JM; Li Q; You S; Kim J; Lu YT; Mrdenovic S; Wang R; Freeman MR; Garraway I; Lewis MS; Chung LW; Zhau HE
Oncotarget; 2016 Dec; 7(51):84645-84657. PubMed ID: 27835867
[TBL] [Abstract][Full Text] [Related]
3. Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.
Holen I; Whitworth J; Nutter F; Evans A; Brown HK; Lefley DV; Barbaric I; Jones M; Ottewell PD
Breast Cancer Res; 2012 May; 14(3):R86. PubMed ID: 22632416
[TBL] [Abstract][Full Text] [Related]
4. CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling.
Peng F; Yang C; Kong Y; Huang X; Chen Y; Zhou Y; Xie X; Liu P
Curr Cancer Drug Targets; 2020; 20(2):156-165. PubMed ID: 31744448
[TBL] [Abstract][Full Text] [Related]
5. DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.
Chen YJ; Lee LY; Chao YK; Chang JT; Lu YC; Li HF; Chiu CC; Li YC; Li YL; Chiou JF; Cheng AJ
PLoS One; 2013; 8(5):e64088. PubMed ID: 23737966
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.
Sang Y; Sun L; Wu Y; Yuan W; Liu Y; Li SW
Int J Oncol; 2019 Mar; 54(3):1112-1122. PubMed ID: 30628670
[TBL] [Abstract][Full Text] [Related]
7. Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.
Liu S; Cadaneanu RM; Zhang B; Huo L; Lai K; Li X; Galet C; Grogan TR; Elashoff D; Freedland SJ; Rettig M; Aronson WJ; Knudsen BS; Lewis MS; Garraway IP
PLoS One; 2016; 11(10):e0163232. PubMed ID: 27711225
[TBL] [Abstract][Full Text] [Related]
8. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.
Luo P; Zhang C; Liao F; Chen L; Liu Z; Long L; Jiang Z; Wang Y; Wang Z; Liu Z; Miao H; Shi C
Cell Commun Signal; 2019 Apr; 17(1):36. PubMed ID: 30992017
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival.
Lu L; Zeng H; Gu X; Ma W
Breast Cancer Res Treat; 2015 Jun; 151(3):491-500. PubMed ID: 25957595
[TBL] [Abstract][Full Text] [Related]
11. Plakoglobin restores tumor suppressor activity of p53
Alaee M; Nool K; Pasdar M
Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
[TBL] [Abstract][Full Text] [Related]
12. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.
Zhang C; Xu B; Lu S; Zhao Y; Liu P
Mol Cancer; 2017 May; 16(1):90. PubMed ID: 28490334
[TBL] [Abstract][Full Text] [Related]
13. SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis.
Ali A; Shafarin J; Muhammad JS; Farhat NM; Hamad M; Soofi A; Hamad M
Cell Signal; 2023 Apr; 104():110591. PubMed ID: 36627007
[TBL] [Abstract][Full Text] [Related]
14. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
15. PYCR2, induced by c-Myc, promotes the invasiveness and metastasis of breast cancer by activating AKT signalling pathway.
Wu G; Qin S; Gu K; Zhou Y
Int J Biochem Cell Biol; 2024 Jan; 166():106506. PubMed ID: 38101533
[TBL] [Abstract][Full Text] [Related]
16. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
Sheng S; Barnett DH; Katzenellenbogen BS
Mol Cell Endocrinol; 2008 Dec; 296(1-2):1-9. PubMed ID: 18951949
[TBL] [Abstract][Full Text] [Related]
17. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.
Wang X; Peng J; Yang Z; Zhou PJ; An N; Wei L; Zhu HH; Lu J; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2019 Jan; 38(1):27. PubMed ID: 30665442
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
20. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
Aktary Z; Pasdar M
PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
